Skip to main content

Brimonidine Tartrate

Generic: brimonidine tartrate

Verified·Oct 26, 2026
Manufacturer
Allergan
NDC
82182-321
RxCUI
861204
Route
OPHTHALMIC
ICD-10 indication
H40.10

Affordability Check

How much will you actually pay for Brimonidine Tartrate?

In 30 seconds, see every legitimate way to afford Brimonidine Tartrate — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Brimonidine Tartrate

What is this medication? Brimonidine tartrate is a prescription medication primarily used to lower internal eye pressure in patients with open-angle glaucoma or ocular hypertension. As an alpha-2 adrenergic agonist, it functions by reducing the production of aqueous humor, which is the fluid inside the eye, while simultaneously increasing the amount of fluid that drains out. By managing intraocular pressure, the medication helps prevent damage to the optic nerve and protects against potential vision loss.

Beyond its ophthalmic applications, this medication is also available in a topical gel form to treat the persistent facial redness caused by rosacea. When applied to the skin, it works by constricting dilated blood vessels to provide a temporary reduction in redness and flushing. Regardless of the form prescribed, it is important to use the medication exactly as directed by a physician, as it may cause side effects such as eye redness, itching, or skin irritation in some individuals.

Copay & patient assistance

  • Patient Copay Amount: $15 per 30-, 60-, or 90-day supply
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Eligible commercially-insured patients only; offer not valid for patients enrolled in Medicare, Medicaid, or other state or federal healthcare programs
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Brimonidine Tartrate. Official source: DailyMed (NLM) · Label effective Mar 31, 2026

Indications and usage
Use relieves redness of the eye due to minor eye irritations
Dosage and administration
Directions adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use children under 5 years of age: consult a doctor
Warnings
Warnings For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Brimonidine Tartrate appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

44%

2,402 of 5,499 plans

Most common tier

Tier 3

On 35% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)54
26%
Tier 2 (generic)47
22%
Tier 3 (preferred brand)73
35%
Tier 4 (non-preferred brand)37
18%

Step therapy: 0% of formularies

Quantity limits: 1% of formularies

Coverage breadth: 211 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.